BRAF and thyroid gland papillary carcinoma: In thyroid, BRAF V600E mutation is restricted to malignant tumors, and is associated with papillary thyroid cancer (PTC), and PTC-derived poorly-differentiated and anaplastic carcinoma [7,8].